NCT07021989
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07021989
Title ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Michael Spinner, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California Davis NOT_YET_RECRUITING Davis California 95616 United States Details
University of California San Francisco-Fresno NOT_YET_RECRUITING Fresno California 93701 United States Details
University of California Irvine NOT_YET_RECRUITING Irvine California 92617 United States Details
University of California, San Diego NOT_YET_RECRUITING La Jolla California 92093 United States Details
Unversity of California, Los Angeles NOT_YET_RECRUITING Los Angeles California 90095 United States Details
University of California, San Francisco RECRUITING San Francisco California 94143 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field